SCHEMBL4030757

SCHEMBL4030757

COP(=O)(Cc1ccccc1N)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.43
ALDH1A1 P00352 9/20 0.42
KDM4E B2RXH2 3/20 0.42
HPGD P15428 3/20 0.42
RCE1 Q9Y256 1/20 0.42
HSD17B10 Q99714 3/20 0.40
CFTR P13569 1/20 0.40
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ADRA2B P18089 1/20 0.38
PTGS1 P23219 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.37
LMNA P02545 2/20 0.35
RECQL P46063 1/20 0.35
CA2 P00918 1/20 0.34
LAP3 P28838 1/20 0.34
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6575682 0.86 TSHR (0.46) ALDH1A1HPGDHTTL3MBTL1TSHR
SCHEMBL331041 0.81 FDPS (0.41) FDPSALDH1A1HSD17B10TSHRPOLB
SCHEMBL8958927 0.78 HPGD (0.43) ALDH1A1KDM4EHPGDHTTL3MBTL1
SCHEMBL8959136 0.77 IDO1 (0.42) ALDH1A1KDM4EHPGDHTTL3MBTL1
SCHEMBL8958923 0.77 IDO1 (0.42) ALDH1A1HTTL3MBTL1TDP1LMNA
SCHEMBL11710711 0.77 TSHR (0.53) HTTL3MBTL1TSHRLMNACA2
SCHEMBL9021319 0.77 TSHR (0.40) ALDH1A1HPGDHTTL3MBTL1TSHR
SCHEMBL28479763 0.77 IDO1 (0.42) ALDH1A1HPGDHTTL3MBTL1TDP1
SCHEMBL6384988 0.77 IDO1 (0.42) ALDH1A1KDM4EHPGDHTTL3MBTL1
SCHEMBL9169326 0.76 ACP3 (0.40) ALDH1A1KDM4EHTTL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537075-B1 DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH AS (DK) 2009-07-01 EP disclosed
US-20060160856-A1 Diarylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2006-07-20 US disclosed
EP-1537075-A2 DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH A/S (DK) 2005-06-08 EP disclosed
WO-2004022529-A2 DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH A/S (DK) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160856-A1 Diarylurea derivatives and their use as chloride channel blockers KIT, ORAI1, CACNA1C FDPS 1125/4885ALDH1A1 1538/4885KDM4E 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.